Vaxxinity (VAXX) Institutional Ownership $0.03 -0.03 (-50.00%) (As of 07/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Vaxxinity (NASDAQ:VAXX)CurrentInstitutional OwnershipPercentage82.95%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$179.95KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$57.06K Get VAXX Insider Trade Alerts Want to know when executives and insiders are buying or selling Vaxxinity stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VAXX Institutional Buying and Selling by Quarter Ad American Hartford Gold GroupPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE Vaxxinity Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/7/2024Ieq Capital LLC83,262$71K0.0%N/A0.066% 11/7/2023New York State Common Retirement Fund23,642$32K0.0%-46.4%0.019% 10/31/2023 McAdam LLC68,281$94K0.0%+47.4%0.054% 10/24/2023 Bank of New York Mellon Corp121,522$166K0.0%-14.8%0.096% 10/19/2023 Clarius Group LLC20,000$27K0.0%N/A0.016% 8/4/2023American International Group Inc.20,514$52K0.0%N/A0.016% 7/25/2023 Raymond James Financial Services Advisors Inc.17,001$43K0.0%+69.7%0.013% 5/3/2023Integrated Wealth Concepts LLC11,000$25K0.0%N/A0.009% 5/2/2023 Lincoln National Corp41,070$93K0.0%N/A0.033% 5/1/2023Virtu Financial LLC12,263$28K0.0%-31.3%0.010% 4/24/2023 McAdam LLC46,324$105K0.0%N/A0.037% 4/21/2023 Blue Zone Wealth Advisors LLC27,500$62K0.0%N/A0.022% 4/18/2023ETF Managers Group LLC43,836$100K0.0%+39.5%0.035% 3/23/2023ETF Managers Group LLC31,427$44K0.0%-15.5%0.025% 11/15/2022Prime Movers Lab LLC17,603,276$31.37M22.6%-1.4%13.968% 11/4/2022First Republic Investment Management Inc.199,022$394K0.0%N/A0.158% 8/10/2022 Clarius Group LLC20,000$31K0.0%N/A0.016% 7/22/2022Truist Financial Corp20,738$33K0.0%N/A0.016% 7/21/2022Hollencrest Capital Management20,000$31K0.0%N/A0.016% 3/10/2022Prime Movers Lab LLC18,027,314$91.02M17.4%N/A14.377% 2/15/2022Adage Capital Partners GP L.L.C.1,001,670$5.62M0.0%N/A0.799% 2/14/2022ETF Managers Group LLC37,884$211K0.0%N/A0.030% 2/1/2022FNY Investment Advisers LLC4,847$27K0.0%N/A0.004% (Data available from 1/1/2016 forward) VAXX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VAXX shares? During the previous two years, 14 institutional investors and hedge funds held shares of Vaxxinity. The most heavily invested institutionals were Prime Movers Lab LLC ($31.37M), First Republic Investment Management Inc. ($394K), Bank of New York Mellon Corp ($166K), ETF Managers Group LLC ($100K), McAdam LLC ($94K), Lincoln National Corp ($93K), and Ieq Capital LLC ($71K).Learn more on VAXX's institutional investors. What percentage of Vaxxinity stock is owned by institutional investors? 82.95% of Vaxxinity stock is owned by institutional investors. Learn more on VAXX's institutional investor holdings. Which institutional investors have been buying Vaxxinity stock? Of the 10 institutional investors that purchased Vaxxinity stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: First Republic Investment Management Inc. ($199.02K), Ieq Capital LLC ($83.26K), McAdam LLC ($68.28K), Lincoln National Corp ($41.07K), Clarius Group LLC ($40K), Blue Zone Wealth Advisors LLC ($27.50K), and American International Group Inc. ($20.51K). How much institutional buying is happening at Vaxxinity? Institutional investors have bought a total of 510,043 shares in the last 24 months. This purchase volume represents approximately $936.96K in transactions. Which Vaxxinity major shareholders have been selling company stock? The following institutional investors have sold Vaxxinity stock in the last 24 months: Prime Movers Lab LLC ($245.04K), Bank of New York Mellon Corp ($21.19K), New York State Common Retirement Fund ($20.46K), ETF Managers Group LLC ($5.76K), and Virtu Financial LLC ($5.58K). How much institutional selling is happening at Vaxxinity? Institutional investors have sold a total of 298,030 shares in the last 24 months. This volume of shares sold represents approximately $562.97K in transactions. Related Companies: Seres Therapeutics Institutional Ownership Rezolute Institutional Ownership Puma Biotechnology Institutional Ownership FibroBiologics Institutional Ownership scPharmaceuticals Institutional Ownership G1 Therapeutics Institutional Ownership Organigram Institutional Ownership Atossa Therapeutics Institutional Ownership Syros Pharmaceuticals Institutional Ownership Lifecore Biomedical Institutional Ownership This page (NASDAQ:VAXX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWhy is NVDA stumbling?July is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxxinity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxxinity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.